News Highlights

June 2, 2009
Concert Pharmaceuticals and GlaxoSmithKline Form
Alliance to Develop Novel Deuterium Modified Drugs

June 1, 2009
Concert Pharmaceuticals to Participate in the Private Company Forum at the 30th Annual Goldman Sachs Global Healthcare Conference

May 11, 2009
Concert Pharmaceuticals Granted Patents on Deuterium-Modified Compounds

March 16, 2009
Concert Pharmaceuticals Announces Positive Results from Phase I Clinical Study of CTP-347

more...

Welcome to Concert

Concert uses precision deuterium chemistry to create novel first- and best-in-class medicines, leveraging clinically proven drugs to reduce risk.

Upcoming Events

Concert will present at the Thomas Weisel Partners 2009 Healthcare Conference being held September 9-11, 2009 in Boston, MA.

Concert in the news... a selection of news stories featuring Concert.